News | September 20, 2011

RaySearch enters distribution agreement for the Italian market

September 20, 2011 – RaySearch Laboratories AB has entered into an exclusive distribution agreement with the Italian distributor Tecnologie Avanzate T.A. S.r.l. based in Torino, Italy. The agreement means that Tecnologie Avanzate will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the Italian market.

RaySearch started marketing RayStation on the U.S. market in the beginning of 2011. This new distribution agreement marks the starting point in the build-up of the European sales and marketing function. In continental Europe, RaySearch will use a mixed model and be directly responsible for sales and marketing in certain markets and use local distributors in others. Italy is one of the largest radiation therapy markets in Europe with more than 150 radiation therapy clinics, and the technology level is generally high, with a long tradition of utilizing more advanced techniques such as intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT).

Tecnologie Avanzate has approximately 20 employees and is a leading distributor of radiation therapy equipment in Italy. The company represents a wide range of international radiation therapy equipment suppliers and has been active for more than fifteen years in marketing, sales and service of treatment planning systems in particular.

For more information: www.raysearchlabs.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init